New pill shows promise for stiff heart disease
NCT ID NCT06347159
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 37 times
Summary
This study tests a new medicine called EDG-7500 in 100 adults with hypertrophic cardiomyopathy, a condition where the heart muscle is too thick. The goal is to see if the drug is safe and can help reduce pressure inside the heart. Participants will receive either a single or multiple doses, and doctors will monitor their heart function and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Duke Health Center Arringdon
Morrisville, North Carolina, 27560, United States
-
Emory Clinic
Atlanta, Georgia, 30322, United States
-
Hospital of the University of Pennsylvania (University of Pennsylvania School of Medicine)
Philadelphia, Pennsylvania, 19104, United States
-
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Michigan Medicine - Michigan Clinical Research Unit
Ann Arbor, Michigan, 48109, United States
-
Morristown Medical Center (Atlantic Health System)
Morristown, New Jersey, 07960, United States
-
NYU Langone Health Medical Center - HCM Program Office (Study open to existing NYU patients only)
New York, New York, 10016, United States
-
North Shore University Hospital
Manhasset, New York, 11030, United States
-
Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
-
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, 64111, United States
-
Sanger Heart and Vascular Institute
Charlotte, North Carolina, 28204, United States
-
Stanford University Hospital / Stanford Health Care
Stanford, California, 94305, United States
-
The Lindner Research Center at Christ Hospital
Cincinnati, Ohio, 45219, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 33612, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Virginia Heart and Vascular Center Fontaine
Charlottesville, Virginia, 22903, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
Conditions
Explore the condition pages connected to this study.